Breast Malignant Phyllodes Tumor disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: BRS007 MIFTS: 45	Breast Malignant Phyllodes Tumor Categories: Cancer diseases, Rare diseases, Reproductive diseases
Genes Tissues Related diseases Publications Pathways Drugs Collapse all tables

Sources

Aliases & Classifications for Breast Malignant Phyllodes Tumor

MalaCards integrated aliases for Breast Malignant Phyllodes Tumor:

Name: Breast Malignant Phyllodes Tumor ¹² ¹⁵

Cystosarcoma Phyllodes of the Breast ⁵² ⁵⁸

Malignant Phyllodes Tumor of Breast ¹² ⁷¹

Malignant Cystosarcoma Phyllodes ¹² ⁷¹

Phyllodes Tumor of the Breast ⁵² ⁵⁸

Phyllodes Breast Tumor ¹² ⁵²

Malignant Mammary Phyllodes Tumor ¹²

Malignant Breast Phyllodes Tumor ¹⁷

Malignant Phyllodes Neoplasm ¹²

Phyllodes Tumor, Malignant ¹²

Malignant Phyllodes Tumor ¹²

Phyllodes Breast Neoplasm ¹²

Cystosarcoma Phyllodes ⁵²

Breast Phyllodes Tumor ⁷¹

Phylloides Tumor ⁵²

Phyllodes Tumor ⁷¹

Characteristics:

Orphanet epidemiological data:

⁵⁸

phyllodes tumor of the breast
Age of onset: Adult;

Classifications:

MalaCards categories:
Global: Rare diseases Cancer diseases
Anatomical: Reproductive diseases

See all MalaCards categories (disease lists)

ICD10: ³³

Neoplasms

Neoplasms of uncertain or unknown behaviour

Neoplasm of uncertain or unknown behaviour of other and unspecified sites

Neoplasm of uncertain or unknown behaviour: Breast

Orphanet: ⁵⁸

Rare gynaecological and obstetric diseases

External Ids:

Disease Ontology ¹² DOID:3016

MeSH ⁴³ D003557

NCIt ⁴⁹ C4275 C4504 C7575

SNOMED-CT ⁶⁷ 87913009

MESH via Orphanet ⁴⁴ D003557

ICD10 via Orphanet ³³ D48.6

UMLS via Orphanet ⁷² C0010701

Orphanet ⁵⁸ ORPHA180261

EFO ¹⁷ EFO_0008545

UMLS ⁷¹ C0010701 C0238031 C0346154 more

Sources

Summaries for Breast Malignant Phyllodes Tumor

NIH Rare Diseases : ⁵² Phyllodes tumors of the breast are rare tumors that start in the connective (stromal) tissue of the breast. They get their name from the leaf-like pattern in which they grow (phyllodes means leaf-like in Greek). They are most common in women in their 30s and 40s, although women of any age can be affected. These tumors, which are usually painless, tend to grow quickly, but rarely spread outside of the breast. Most phyllodes tumors are benign. About 1 in 10 are cancerous. The underlying cause of these tumors in unknown. Surgery is the main treatment. Because the tumors can reoccur if they are not removed with enough surrounding tissue, the tumor and at least 1 cm of tissue should be removed. Cancerous phyllodes tumors are often treated with mastectomy. Close follow-up with frequent breast examinations are recommended after surgery.

MalaCards based summary : Breast Malignant Phyllodes Tumor, also known as cystosarcoma phyllodes of the breast, is related to li-fraumeni syndrome and scirrhous adenocarcinoma. An important gene associated with Breast Malignant Phyllodes Tumor is SERPINA3 (Serpin Family A Member 3), and among its related pathways/superpathways are MAPK signaling pathway and Pathways in cancer. The drugs Fluorouracil and Belinostat have been mentioned in the context of this disorder. Affiliated tissues include breast, prostate and lung, and related phenotypes are cellular and integument

Disease Ontology : ¹² A breast cancer that is characterized by a prominent infiltrative border, unequivocal sarcomatous areas, and stromal overgrowth and arises from the stroma, lined by an epithelial and myoepithelial bilayer, forming a leaflike structure. They tend to grow rapidly and present in middle-aged women (40s-50s).

Sources

Related Diseases for Breast Malignant Phyllodes Tumor

Diseases in the Benign Breast Phyllodes Tumor family:

Breast Malignant Phyllodes Tumor

Diseases related to Breast Malignant Phyllodes Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 507, show less)

#	Related Disease	Score	Top Affiliating Genes
1	li-fraumeni syndrome	31.8	TP53 ESR1 ERBB2 EGFR
2	scirrhous adenocarcinoma	30.9	PGR ERBB2
3	gynecomastia	30.9	PGR ESR1 ERBB2
4	soft tissue sarcoma	30.8	TP53 EGFR
5	benign mesothelioma	30.6	KRT5 CD34
6	leiomyoma, uterine	30.5	PGR MED12 ESR1
7	malignant mesenchymoma	30.5	SERPINA3 CD34
8	benign breast phyllodes tumor	30.4	PGR MME MED12 KIT
9	bilateral breast cancer	30.3	PGR ESR1 ERBB2
10	mesenchymoma	30.2	SERPINA3 KIT CD34
11	spindle cell carcinoma	30.2	PGR KRT5 ESR1 CD34
12	hypertrophy of breast	30.2	TP53 PGR ESR1 ERBB2
13	female breast cancer	30.2	TP53 PGR ESR1 ERBB2
14	angiosarcoma	30.0	TP53 KIT CD34
15	histiocytoma	30.0	TP53 SERPINA3 KIT CD34
16	adenocarcinoma	30.0	TP53 KIT ERBB2 EGFR
17	embryonal sarcoma	30.0	TP53 SERPINA3 KIT
18	neurilemmoma	29.9	SERPINA3 KIT CD34
19	mammary paget's disease	29.9	PGR ESR1 ERBB2 EGFR
20	intraductal papilloma	29.8	PGR KRT5 ESR1 ERBB2
21	prostatic hypertrophy	29.8	SERPINA3 PGR ESR1 EGFR
22	inflammatory breast carcinoma	29.7	PGR ESR1 ERBB2 EGFR
23	breast fibroadenoma	29.7	TP53 SERPINA3 PGR MME MED12 ESR1
24	lobular neoplasia	29.7	TP53 PGR KRT5 ESR1 ERBB2
25	tubular adenocarcinoma	29.7	PGR MME ESR1 ERBB2 EGFR
26	papilloma	29.5	TP53 KRT5 ESR1 EGFR
27	leiomyosarcoma	29.5	TP53 SERPINA3 PGR MED12 KIT ESR1
28	breast disease	29.4	TP53 SERPINA3 PGR KRT5 ESR1 ERBB2
29	microglandular adenosis	29.3	TP53 PGR ESR1 ERBB2 EGFR
30	in situ carcinoma	29.3	TP53 PGR KRT5 ESR1 ERBB2 EGFR
31	mesenchymal cell neoplasm	29.2	TP53 SERPINA3 MME KIT CD34
32	leiomyoma	29.1	PGR MME MED12 KIT ESR1 CD34
33	cribriform carcinoma	29.1	PGR KRT5 KIT ESR1 ERBB2
34	gastrointestinal stromal tumor	29.0	TP53 KIT ERBB2 EGFR CD34
35	breast adenocarcinoma	29.0	TP53 SERPINA3 PGR MED12 ESR1 ERBB2
36	breast sarcoma	28.8	TP53 PGR MME ESR1 ERBB2 CD34
37	carcinosarcoma	28.7	TP53 PGR MME KIT ERBB2 EGFR
38	adenosarcoma	28.6	TP53 SERPINA3 PGR MME KIT ESR1
39	ductal carcinoma in situ	28.5	TP53 PGR MME KRT5 ESR1 ERBB2
40	benign prostate phyllodes tumor	11.5
41	li-fraumeni syndrome 2	11.4
42	rare tumor	10.7
43	sarcoma	10.6
44	spindle cell sarcoma	10.6
45	liposarcoma	10.5
46	rare breast tumor	10.5
47	fibrosarcoma	10.5
48	adenoma	10.5
49	congenital epulis	10.5	SERPINA3 PGR
50	epulis	10.5	SERPINA3 PGR
51	diffuse peritoneal leiomyomatosis	10.5	PGR MED12
52	peritoneal benign neoplasm	10.5	PGR MED12
53	non-proliferative fibrocystic change of the breast	10.5	SERPINA3 ERBB2
54	bartholin's gland adenoid cystic carcinoma	10.4	PGR ESR1
55	chronic tympanitis	10.4	PGR ESR1
56	granulomatous endometritis	10.4	PGR ESR1
57	lung leiomyoma	10.4	PGR ESR1
58	vulvar syringoma	10.4	PGR ESR1
59	trigonitis	10.4	PGR ESR1
60	adult type testicular granulosa cell tumor	10.4	PGR ESR1
61	breast adenoid cystic carcinoma	10.4	PGR ERBB2
62	osteogenic sarcoma	10.4
63	infant gynecomastia	10.4
64	meningothelial meningioma	10.4	SERPINA3 PGR
65	skull base cancer	10.4	SERPINA3 PGR
66	xanthogranulomatous cholecystitis	10.4	TP53 SERPINA3
67	mammographic density	10.4	PGR ESR1
68	skull base meningioma	10.4	SERPINA3 PGR
69	linitis plastica	10.4	PGR ERBB2
70	gastric papillary adenocarcinoma	10.4	TP53 ERBB2
71	pulmonary vein leiomyosarcoma	10.4	PGR CD34
72	sebaceous adenoma	10.4	SERPINA3 ESR1
73	vagina leiomyoma	10.4	PGR CD34
74	lung meningioma	10.4	PGR CD34
75	breast squamous cell carcinoma	10.4	TP53 ERBB2
76	liver sarcoma	10.4	SERPINA3 CD34
77	parotid gland cancer	10.4	TP53 ERBB2
78	pleomorphic adenoma carcinoma	10.4	TP53 ERBB2
79	gastric squamous cell carcinoma	10.4	SERPINA3 KRT5
80	papillary adenoma	10.3	TP53 KRT5
81	pregnancy adenoma	10.3	PGR KRT5
82	breast cystic hypersecretory carcinoma	10.3	KRT5 ERBB2
83	progesterone resistance	10.3	PGR ESR1
84	external ear carcinoma	10.3	PGR KRT5
85	chondrosarcoma	10.3
86	malignant fibroxanthoma	10.3
87	constipation	10.3
88	fibrous histiocytoma	10.3
89	48,xyyy	10.3
90	undifferentiated pleomorphic sarcoma	10.3
91	glomangiosarcoma	10.3	TP53 CD34
92	intravascular fasciitis	10.3	ESR1 CD34
93	cerebellum cancer	10.3	TP53 SERPINA3
94	vulva basal cell carcinoma	10.3	KRT5 ERBB2
95	large intestine adenocarcinoma	10.3	TP53 ERBB2
96	pediatric angiosarcoma	10.3	TP53 CD34
97	cervical adenomyoma	10.3	PGR MME
98	gender identity disorder	10.3	PGR ESR1
99	fibromatosis	10.3
100	breast myoepithelial carcinoma	10.3	PGR KRT5
101	malignant spiradenoma	10.3	TP53 KRT5
102	mucoepidermoid esophageal carcinoma	10.3	TP53 KRT5
103	tenosynovial giant cell tumor	10.3	SERPINA3 CD34
104	breast hemangioma	10.3	TP53 CD34
105	cervical serous adenocarcinoma	10.3	PGR MME
106	ovarian carcinosarcoma	10.3	TP53 ERBB2
107	recurrent respiratory papillomatosis	10.3	ERBB2 EGFR
108	cystic lymphangioma	10.3	SERPINA3 CD34
109	atypical polypoid adenomyoma	10.3	MME MED12
110	granulosa cell tumor of the ovary	10.3	TP53 ERBB2
111	lung leiomyosarcoma	10.3	KRT5 CD34
112	esophageal adenosquamous carcinoma	10.3	KRT5 ERBB2
113	necrotizing sialometaplasia	10.3	TP53 KRT5
114	spermatic cord cancer	10.3	KRT5 CD34
115	gastrointestinal lymphoma	10.3	SERPINA3 MME
116	cellular leiomyoma	10.3	MME MED12
117	myofibroma	10.3	SERPINA3 CD34
118	ovarian endometrial cancer	10.3	SERPINA3 PGR ESR1
119	eccrine sweat gland cancer	10.3	TP53 KRT5
120	infantile digital fibromatosis	10.2
121	eccrine acrospiroma	10.2	TP53 KRT5
122	pediatric fibrosarcoma	10.2	SERPINA3 CD34
123	large cell acanthoma	10.2	TP53 KRT5
124	papillary carcinoma	10.2	PGR ESR1 ERBB2
125	pancreatic mucinous cystadenoma	10.2	PGR MME
126	pelvic lipomatosis	10.2	MED12 CD34
127	testicular fibroma	10.2	KRT5 CD34
128	glassy cell carcinoma of the cervix	10.2	PGR ESR1 ERBB2
129	cutaneous solitary mastocytoma	10.2	SERPINA3 KIT
130	breast juvenile papillomatosis	10.2	PGR ESR1 ERBB2
131	type c thymoma	10.2	SERPINA3 KIT
132	oncocytic breast carcinoma	10.2	PGR ESR1 ERBB2
133	clear cell meningioma	10.2	PGR CD34
134	esophagus verrucous carcinoma	10.2	TP53 EGFR
135	metatypical basal cell carcinoma	10.2	KRT5 CD34
136	hepatoid adenocarcinoma	10.2	SERPINA3 EGFR
137	adult malignant schwannoma	10.2	TP53 CD34
138	well-differentiated liposarcoma	10.2
139	breast neuroendocrine neoplasm	10.2	PGR ESR1 ERBB2
140	pacinian tumor	10.2	MME CD34
141	frontal lobe neoplasm	10.2	TP53 EGFR
142	progesterone-receptor positive breast cancer	10.2	PGR ESR1 ERBB2
143	pleomorphic lipoma	10.2	SERPINA3 PGR CD34
144	benign mesenchymoma	10.2	KRT5 CD34
145	signet ring cell adenocarcinoma	10.2	TP53 SERPINA3 ERBB2
146	serous cystadenocarcinoma	10.2	TP53 PGR ERBB2
147	estrogen excess	10.2	PGR ESR1
148	apocrine adenosis of breast	10.2	TP53 PGR ERBB2
149	papillary adenocarcinoma	10.2	TP53 PGR ERBB2
150	glandular cystitis	10.2	TP53 MME
151	teeth hard tissue disease	10.2	PGR ESR1 ERBB2
152	gastric diffuse adenocarcinoma	10.2	TP53 PGR ERBB2
153	inflammatory liposarcoma	10.2	MME CD34
154	bartholin's gland adenoma	10.2	TP53 PGR ESR1
155	bartholin's gland benign neoplasm	10.2	TP53 PGR ESR1
156	vestibular gland benign neoplasm	10.2	TP53 PGR ESR1
157	ovarian seromucinous carcinoma	10.2	TP53 PGR ESR1
158	uterine corpus serous adenocarcinoma	10.2	TP53 ERBB2
159	benign breast adenomyoepithelioma	10.2	KRT5 EGFR
160	subareolar duct papillomatosis	10.2	MME KRT5
161	central nervous system leukemia	10.2	MME CD34
162	biliary tract cancer	10.2	ERBB2 EGFR
163	nipple neoplasm	10.2	MME KRT5
164	celiac disease 1	10.2
165	lymphoma	10.2
166	desmoid tumor	10.2
167	prostate malignant phyllodes tumor	10.2
168	mastitis	10.2
169	ovarian brenner tumor	10.2
170	breast pericanalicular fibroadenoma	10.2
171	rhabdomyosarcoma	10.2
172	seminal vesicle tumor	10.2
173	prostate sarcoma	10.2
174	breast rhabdomyosarcoma	10.2
175	holoprosencephaly	10.2
176	pleomorphic liposarcoma	10.2
177	breast fibrosarcoma	10.2
178	paraplegia	10.2
179	breast giant fibroadenoma	10.2
180	sarcomatosis	10.2
181	hypoglycemia	10.2
182	chromosomal triplication	10.2
183	prostatic stromal proliferation of uncertain malignant potential	10.2
184	posttransplant acute limbic encephalitis	10.2
185	rare soft tissue tumor	10.2
186	clear cell adenocarcinoma	10.2	TP53 PGR ESR1
187	endosalpingiosis	10.2	TP53 PGR ESR1
188	fallopian tube endometrioid adenocarcinoma	10.2	MME ERBB2
189	adenoid squamous cell carcinoma	10.2	KRT5 CD34
190	vaginal cancer	10.2	TP53 PGR ESR1
191	endocervical carcinoma	10.2	TP53 PGR ESR1
192	endocervical adenocarcinoma	10.2	TP53 PGR ESR1
193	fibrosarcoma of bone	10.2	SERPINA3 KIT
194	sclerosing hepatic carcinoma	10.2	MME CD34
195	clear cell basal cell carcinoma	10.2	TP53 KRT5
196	cervix erosion	10.2	MME KRT5
197	spinal cord sarcoma	10.2	KIT CD34
198	pelvic organ prolapse	10.2	TP53 PGR ESR1
199	islet cell tumor	10.2
200	spinal cord oligodendroglioma	10.2	TP53 EGFR
201	gallbladder leiomyoma	10.2	KIT CD34
202	bladder leiomyoma	10.2	KIT CD34
203	urethra clear cell adenocarcinoma	10.2	TP53 KRT5
204	vulvar leiomyoma	10.2	PGR ESR1 CD34
205	vulvar benign neoplasm	10.1	PGR ESR1 CD34
206	breast hemangiopericytoma	10.1	KIT CD34
207	small intestinal sarcoma	10.1	KIT CD34
208	small intestine leiomyosarcoma	10.1	KIT CD34
209	colon leiomyosarcoma	10.1	KIT CD34
210	clear cell hidradenoma	10.1	MME KRT5
211	hidradenoma	10.1	MME KRT5
212	intratubular embryonal carcinoma	10.1	TP53 KIT
213	lipid-rich breast carcinoma	10.1	PGR KRT5 ERBB2
214	colon leiomyoma	10.1	MED12 KIT
215	pulmonary artery leiomyosarcoma	10.1	MME CD34
216	endometrial hyperplasia	10.1	TP53 PGR ESR1
217	breast mucinous carcinoma	10.1	PGR KRT5 ERBB2
218	mucinous tubular and spindle renal cell carcinoma	10.1	MME CD34
219	nephrogenic adenoma of the urethra	10.1	MME KRT5
220	urethral benign neoplasm	10.1	MME KRT5
221	gastroesophageal junction adenocarcinoma	10.1	ERBB2 EGFR
222	gallbladder leiomyosarcoma	10.1	KIT CD34
223	deep leiomyoma	10.1	KIT CD34
224	respiratory failure	10.1
225	breast liposarcoma	10.1
226	papillary squamous carcinoma	10.1	KRT5 EGFR
227	eccrine sweat gland neoplasm	10.1	MME KRT5
228	heart leiomyosarcoma	10.1	KIT CD34
229	balloon cell malignant melanoma	10.1	MME KRT5
230	plexiform schwannoma	10.1	KIT CD34
231	small intestine leiomyoma	10.1	KIT CD34
232	bladder clear cell adenocarcinoma	10.1	TP53 MME
233	retroperitoneal hemangiopericytoma	10.1	KIT CD34
234	chordoid glioma	10.1	TP53 PGR
235	jejunal neoplasm	10.1	KIT CD34
236	epididymis adenocarcinoma	10.1	MME KRT5
237	epididymis cancer	10.1	MME KRT5
238	retroperitoneal leiomyosarcoma	10.1	KIT CD34
239	paronychia	10.1	SERPINA3 ERBB2 EGFR
240	polyclonal hypergammaglobulinemia	10.1	SERPINA3 MME
241	mixed glioma	10.1	TP53 EGFR
242	cutaneous ganglioneuroma	10.1	KIT CD34
243	nasal cavity olfactory neuroblastoma	10.1	MME KRT5
244	pharynx cancer	10.1	TP53 SERPINA3 EGFR
245	liver leiomyosarcoma	10.1	KIT CD34
246	ceruminous adenocarcinoma	10.1	KRT5 KIT
247	liver fibroma	10.1	KRT5 KIT
248	fasciitis	10.1	TP53 ESR1 CD34
249	breast cancer	10.1
250	kidney cancer	10.1
251	dermatitis	10.1
252	47,xyy	10.1
253	overgrowth syndrome	10.1
254	skin benign neoplasm	10.1	SERPINA3 KRT5 CD34
255	intravenous leiomyomatosis	10.1	PGR MME ESR1
256	retroperitoneal sarcoma	10.1	KIT CD34
257	bone squamous cell carcinoma	10.1	TP53 EGFR
258	urethra leiomyoma	10.1	MME KIT
259	sebaceous adenocarcinoma	10.1	TP53 KRT5 ERBB2
260	plasma cell neoplasm	10.1	TP53 SERPINA3 MME
261	peritoneal mesothelioma	10.1	PGR ESR1 EGFR
262	breast leiomyosarcoma	10.0	KIT CD34
263	dermis tumor	10.0	SERPINA3 MME CD34
264	combined thymoma	10.0	KRT5 KIT
265	cutaneous fibrous histiocytoma	10.0	SERPINA3 MME CD34
266	intestinal benign neoplasm	10.0	TP53 SERPINA3 EGFR
267	thymus clear cell carcinoma	10.0	KRT5 KIT
268	gastrointestinal system benign neoplasm	10.0	TP53 SERPINA3 EGFR
269	skin tag	10.0	SERPINA3 CD34
270	cervical polyp	10.0	PGR MME CD34
271	esophagus adenocarcinoma	10.0	TP53 ERBB2 EGFR
272	gallbladder adenocarcinoma	10.0	TP53 ERBB2 EGFR
273	rectum adenocarcinoma	10.0	TP53 ERBB2 EGFR
274	wolffian duct adenocarcinoma	10.0	TP53 MME ESR1
275	borst-jadassohn intraepidermal carcinoma	10.0	TP53 KRT5
276	lymphangioleiomyomatosis	10.0	PGR ESR1 EGFR
277	vulva cancer	10.0	TP53 ERBB2 EGFR
278	endometrial clear cell adenocarcinoma	10.0	TP53 MME ESR1
279	cardiogenic shock	10.0
280	childhood medulloblastoma	10.0	TP53 ERBB2 EGFR
281	fibroma	10.0
282	hypoglycemic coma	10.0
283	hyperinsulinism	10.0
284	subacute delirium	10.0
285	pseudoangiomatous stromal hyperplasia	10.0
286	chordoma	10.0	TP53 SERPINA3 EGFR
287	pancreatic ductal carcinoma	10.0	TP53 ERBB2 EGFR
288	cystadenocarcinoma	10.0	TP53 SERPINA3 PGR ERBB2
289	vagina leiomyosarcoma	10.0	PGR KIT ESR1
290	colon sarcoma	10.0	KIT CD34
291	breast myofibroblastoma	10.0	MME ESR1 CD34
292	hair disease	10.0	TP53 ERBB2 EGFR
293	bile duct adenocarcinoma	10.0	TP53 ERBB2 EGFR
294	juvenile nasopharyngeal angiofibroma	10.0	PGR KIT ESR1
295	dowling-degos disease 1	10.0	KRT5 KIT
296	eccrine papillary adenocarcinoma	10.0	PGR MME KRT5
297	intussusception	10.0
298	ocular motor apraxia	10.0
299	prostatic hyperplasia, benign	10.0
300	aneurysmal bone cysts	10.0
301	myxoid liposarcoma	10.0
302	deficiency anemia	10.0
303	breast abscess	10.0
304	hypogonadotropic hypogonadism	10.0
305	pulmonary edema	10.0
306	obstructive jaundice	10.0
307	squamous cell papilloma	10.0
308	neuroendocrine carcinoma	10.0
309	giant cell tumor	10.0
310	prostatic adenoma	10.0
311	lynch syndrome	10.0
312	bone giant cell tumor	10.0
313	mixed liposarcoma	10.0
314	myxoid chondrosarcoma	10.0
315	severe combined immunodeficiency	10.0
316	megakaryocytic leukemia	10.0
317	krukenberg carcinoma	10.0
318	triploidy	10.0
319	bizarre leiomyoma	10.0	TP53 PGR MED12 ESR1
320	intrahepatic cholangiocarcinoma	10.0	TP53 ERBB2 EGFR
321	lymphoepithelioma-like thymic carcinoma	10.0	KRT5 KIT
322	meckel diverticulum	10.0	KIT CD34
323	malignant spindle cell melanoma	10.0	SERPINA3 KIT CD34
324	testicular disease	10.0	TP53 SERPINA3 KIT
325	uterine anomalies	10.0	TP53 SERPINA3 PGR ESR1
326	hemangiopericytoma, malignant	10.0	SERPINA3 KIT CD34
327	comedo carcinoma	10.0	TP53 PGR ESR1 ERBB2
328	synovium cancer	9.9	SERPINA3 KIT CD34
329	lipomatosis, multiple	9.9	SERPINA3 KIT CD34
330	female reproductive endometrioid cancer	9.9	TP53 PGR ESR1 ERBB2
331	apocrine sweat gland neoplasm	9.9	SERPINA3 PGR KRT5 ERBB2
332	mature teratoma	9.9	TP53 KIT ERBB2
333	leukemia, acute lymphoblastic 3	9.9	TP53 MME CD34
334	cavernous hemangioma	9.9	SERPINA3 KIT CD34
335	prostate stromal sarcoma	9.9	PGR KIT CD34
336	intestinal obstruction	9.9	SERPINA3 KIT CD34
337	fallopian tube carcinoma	9.9	TP53 PGR ESR1 ERBB2
338	giant cell glioblastoma	9.9	TP53 EGFR CD34
339	esophageal basaloid squamous cell carcinoma	9.9	TP53 KRT5 EGFR
340	mastocytosis, cutaneous	9.9	SERPINA3 KIT CD34
341	blood coagulation disease	9.9	SERPINA3 KIT CD34
342	micronodular basal cell carcinoma	9.9	TP53 MME KRT5
343	teratoma	9.9	TP53 KIT ESR1
344	cowden syndrome	9.9	TP53 ERBB2 EGFR
345	adenofibroma	9.9	TP53 MME
346	keratinizing squamous cell carcinoma	9.9	TP53 KRT5 EGFR
347	autosomal genetic disease	9.9	TP53 SERPINA3 ESR1
348	central nervous system cancer	9.9	TP53 SERPINA3 EGFR
349	verrucous carcinoma	9.9	TP53 KRT5 EGFR
350	inverted papilloma	9.9	TP53 KRT5 EGFR
351	esophageal disease	9.9	TP53 ERBB2 EGFR
352	pleural cancer	9.9	TP53 KRT5 EGFR
353	pleural disease	9.9	TP53 KRT5 EGFR
354	central epithelioid sarcoma	9.9	MME KRT5 CD34
355	vulvar proximal-type epithelioid sarcoma	9.9	MME KRT5 CD34
356	breast papillary carcinoma	9.9	PGR KRT5 ESR1 ERBB2
357	lipid-rich carcinoma	9.9	PGR KRT5 ESR1 ERBB2
358	intracystic papillary adenoma	9.9	PGR KRT5 ESR1 ERBB2
359	gliofibroma	9.9	TP53 KIT CD34
360	glomangiomatosis	9.9	TP53 KIT CD34
361	conventional fibrosarcoma	9.9	TP53 KIT CD34
362	neurofibrosarcoma	9.9	TP53 KIT CD34
363	sarcoma, synovial	9.9	SERPINA3 KIT CD34
364	plexiform neurofibroma	9.9	TP53 KIT CD34
365	keratosis	9.9	TP53 KRT5 EGFR
366	adenomyoma	9.9	PGR MME MED12 ESR1
367	nasal cavity cancer	9.9	TP53 KRT5
368	cystic nephroma	9.8	PGR MME KIT
369	perivascular epithelioid cell tumor	9.8	PGR MME KIT
370	inflammatory myofibroblastic tumor	9.8	TP53 KIT CD34
371	breast scirrhous carcinoma	9.8	PGR ESR1 ERBB2 EGFR
372	progesterone-receptor negative breast cancer	9.8	PGR ESR1 ERBB2 EGFR
373	ovarian cystadenocarcinoma	9.8	TP53 SERPINA3 ERBB2 EGFR
374	esophagus sarcoma	9.8	KRT5 KIT CD34
375	amelogenesis imperfecta, type ig	9.8	PGR ESR1 ERBB2 EGFR
376	estrogen-receptor negative breast cancer	9.8	PGR ESR1 ERBB2 EGFR
377	paget disease, extramammary	9.8	KRT5 ERBB2
378	mediastinal cancer	9.8	KRT5 KIT CD34
379	nodular malignant melanoma	9.8	TP53 KIT
380	bone marrow cancer	9.8	TP53 KIT CD34
381	gallbladder disease	9.8	TP53 SERPINA3 ERBB2 EGFR
382	exanthem	9.8	KIT ERBB2 EGFR
383	autonomic nervous system neoplasm	9.8	TP53 SERPINA3 ERBB2 EGFR
384	bladder benign neoplasm	9.8	MME KIT
385	barrett esophagus	9.8	TP53 ERBB2 EGFR
386	hemangioblastoma	9.8	MME EGFR CD34
387	primary peritoneal carcinoma	9.8	TP53 PGR ERBB2 EGFR
388	oral cavity cancer	9.8	TP53 SERPINA3 ERBB2 EGFR
389	bone cancer	9.8	TP53 SERPINA3 ESR1 EGFR
390	cervical mucinous adenocarcinoma	9.8	TP53 PGR MME ESR1
391	transitional cell carcinoma	9.8	TP53 ERBB2 EGFR
392	anus cancer	9.8	TP53 KIT EGFR
393	adenomyosis	9.8	TP53 PGR MME ESR1
394	thymic carcinoma	9.8	TP53 KIT EGFR
395	leiomyomatosis	9.8	PGR MED12 KIT ESR1
396	breast leiomyoma	9.8	PGR MME ESR1 CD34
397	endobronchial leiomyoma	9.8	MME KIT CD34
398	vaginal endometrial stromal sarcoma	9.8	PGR MME ESR1 CD34
399	cervical adenocarcinoma	9.8	TP53 ESR1 ERBB2 EGFR
400	small cell carcinoma	9.8	TP53 KIT EGFR
401	thymoma	9.7	TP53 KIT EGFR
402	small cell cancer of the lung	9.7	TP53 KIT EGFR
403	thoracic cancer	9.7	TP53 SERPINA3 PGR ESR1 ERBB2
404	sarcomatoid squamous cell skin carcinoma	9.7	SERPINA3 MME KRT5 CD34
405	liver leiomyoma	9.7	PGR KIT ESR1 CD34
406	peritoneum cancer	9.7	TP53 KRT5 ERBB2 EGFR
407	connective tissue benign neoplasm	9.7	TP53 SERPINA3 KIT CD34
408	apocrine adenocarcinoma	9.7	SERPINA3 PGR KRT5 ESR1 ERBB2
409	sweat gland disease	9.7	SERPINA3 PGR KRT5 ESR1 ERBB2
410	skeletal muscle cancer	9.7	TP53 SERPINA3 KIT CD34
411	muscle cancer	9.7	TP53 SERPINA3 KIT CD34
412	dermatofibrosarcoma protuberans	9.7	TP53 SERPINA3 KIT CD34
413	pancytopenia	9.7	TP53 SERPINA3 KIT CD34
414	cystadenoma	9.7	SERPINA3 PGR MME KIT
415	hemangioma	9.6	TP53 PGR KIT CD34
416	heart cancer	9.6	SERPINA3 KRT5 KIT CD34
417	respiratory system benign neoplasm	9.6	TP53 KRT5 EGFR CD34
418	cholangiocarcinoma	9.6	TP53 MME ERBB2 EGFR
419	uterus leiomyosarcoma	9.6	PGR KRT5 KIT CD34
420	sweat gland cancer	9.6	TP53 PGR KRT5 ESR1 ERBB2
421	ovarian serous cystadenocarcinoma	9.6	TP53 SERPINA3 PGR ERBB2 EGFR
422	angiomyolipoma	9.6	PGR MME KIT ESR1
423	pleomorphic carcinoma	9.6	TP53 PGR KIT EGFR
424	melanoma, cutaneous malignant 1	9.6	TP53 KIT EGFR
425	uterine body mixed cancer	9.6	TP53 KIT ERBB2 EGFR
426	uterine corpus cancer	9.6	TP53 PGR ESR1 ERBB2 EGFR
427	endometrial adenocarcinoma	9.6	TP53 PGR ESR1 ERBB2 EGFR
428	sporadic breast cancer	9.6	TP53 PGR ESR1 ERBB2 EGFR
429	estrogen-receptor positive breast cancer	9.6	TP53 PGR ESR1 ERBB2 EGFR
430	colorectal adenocarcinoma	9.5	TP53 KIT ERBB2 EGFR
431	cutaneous adenocystic carcinoma	9.5	PGR MME KRT5 KIT
432	gliosarcoma	9.5	TP53 SERPINA3 ERBB2 EGFR CD34
433	bladder urothelial carcinoma	9.5	TP53 KIT ERBB2 EGFR
434	breast metaplastic carcinoma	9.5	PGR KRT5 ESR1 ERBB2 EGFR
435	breast osteosarcoma	9.5	PGR MME KRT5 ESR1 ERBB2
436	large cell carcinoma	9.5	KRT5 KIT ERBB2 EGFR
437	neurofibroma	9.5	TP53 KIT EGFR CD34
438	mucoepidermoid carcinoma	9.5	TP53 SERPINA3 KRT5 ERBB2 EGFR
439	malignant peripheral nerve sheath tumor	9.5	TP53 KIT EGFR CD34
440	thymus gland disease	9.5	TP53 KRT5 KIT EGFR
441	thymus cancer	9.5	TP53 KRT5 KIT EGFR
442	skin squamous cell carcinoma	9.5	TP53 KRT5 KIT EGFR
443	sweat gland neoplasm	9.4	TP53 MME KRT5 ERBB2 CD34
444	large cell neuroendocrine carcinoma	9.4	PGR KIT ESR1 ERBB2 EGFR
445	salivary gland carcinoma	9.4	TP53 SERPINA3 KIT ERBB2 EGFR
446	ovary adenocarcinoma	9.4	TP53 SERPINA3 PGR ESR1 ERBB2 EGFR
447	malignant ovarian surface epithelial-stromal neoplasm	9.4	TP53 SERPINA3 PGR ESR1 ERBB2 EGFR
448	ovary epithelial cancer	9.4	TP53 SERPINA3 PGR ESR1 ERBB2 EGFR
449	glioma susceptibility 1	9.3	TP53 ERBB2 EGFR
450	endometrial stromal sarcoma	9.3	TP53 PGR MME KIT ESR1
451	vagina sarcoma	9.3	PGR MME KIT ESR1 CD34
452	adult mesoblastic nephroma	9.3	PGR MME KIT ESR1 CD34
453	cardiovascular cancer	9.3	TP53 SERPINA3 MME KIT CD34
454	vascular cancer	9.3	TP53 SERPINA3 MME KIT CD34
455	lymphatic system cancer	9.3	TP53 SERPINA3 MME KIT CD34
456	lymphatic system disease	9.3	TP53 SERPINA3 MME KIT CD34
457	leukocyte disease	9.3	TP53 SERPINA3 MME KIT CD34
458	connective tissue cancer	9.3	TP53 SERPINA3 KIT EGFR CD34
459	uterine benign neoplasm	9.3	TP53 PGR MME MED12 ESR1 CD34
460	pancreatic adenocarcinoma	9.3	TP53 KIT ESR1 ERBB2 EGFR
461	gastric adenocarcinoma	9.3	TP53 KIT ESR1 ERBB2 EGFR
462	thyroid gland cancer	9.3	TP53 KIT ESR1 ERBB2 EGFR
463	myocardial infarction	9.3	TP53 SERPINA3 MME ESR1 CD34
464	hematologic cancer	9.3	TP53 SERPINA3 MME KIT CD34
465	leber congenital amaurosis	9.3	TP53 SERPINA3 MME KIT CD34
466	glioblastoma multiforme	9.3	TP53 KIT ESR1 ERBB2 EGFR
467	ewing sarcoma	9.2	TP53 KIT ERBB2 EGFR CD34
468	leukemia, chronic myeloid	9.2	TP53 KIT ERBB2 EGFR CD34
469	dilated cardiomyopathy	9.2	TP53 SERPINA3 ERBB2 EGFR CD34
470	intraductal breast neoplasm	9.2	TP53 PGR MME KRT5 ESR1 ERBB2
471	luminal breast carcinoma	9.2	TP53 PGR KRT5 ESR1 ERBB2 EGFR
472	pre-malignant neoplasm	9.2	TP53 PGR KRT5 ESR1 ERBB2 EGFR
473	breast carcinoma in situ	9.2	TP53 PGR KRT5 ESR1 ERBB2 EGFR
474	breast ductal carcinoma	9.2	TP53 PGR KRT5 ESR1 ERBB2 EGFR
475	neuroblastoma	9.2	TP53 KIT ESR1 ERBB2 EGFR
476	renal cell carcinoma, papillary, 1	9.2	TP53 MME KIT ERBB2 EGFR
477	mucinous adenocarcinoma	9.1	TP53 PGR KIT ESR1 ERBB2 EGFR
478	reproductive organ benign neoplasm	9.1	TP53 SERPINA3 PGR MME MED12 ESR1
479	ovarian disease	9.1	TP53 PGR KIT ESR1 ERBB2 EGFR
480	peripheral nervous system neoplasm	9.1	TP53 SERPINA3 KIT ERBB2 EGFR CD34
481	adenosquamous carcinoma	9.0	TP53 SERPINA3 PGR KRT5 KIT EGFR
482	vulvar disease	9.0	TP53 PGR KIT ERBB2 EGFR CD34
483	salivary gland disease	9.0	TP53 SERPINA3 KRT5 KIT ERBB2 EGFR
484	smooth muscle tumor	8.9	SERPINA3 PGR MME MED12 KIT ESR1
485	leukemia, chronic lymphocytic	8.8	TP53 MME KIT ERBB2 EGFR CD34
486	cell type benign neoplasm	8.8	TP53 SERPINA3 PGR KIT ESR1 EGFR
487	gastric cancer	8.8	TP53 SERPINA3 PGR KIT ESR1 ERBB2
488	oropharynx cancer	8.8	TP53 SERPINA3 PGR KRT5 KIT ERBB2
489	hypertension, essential	8.8	TP53 MME KIT ESR1 EGFR CD34
490	adenoid cystic carcinoma	8.8	TP53 SERPINA3 PGR KRT5 KIT ERBB2
491	suppression of tumorigenicity 12	8.8	TP53 SERPINA3 KRT5 KIT ESR1 ERBB2
492	basal cell carcinoma	8.7	TP53 MME KRT5 KIT EGFR CD34
493	lung cancer susceptibility 3	8.7	TP53 SERPINA3 KRT5 KIT ESR1 ERBB2
494	myoma	8.7	PGR MME MED12 KIT ESR1 EGFR
495	uterine carcinosarcoma	8.7	TP53 PGR MME KIT ESR1 ERBB2
496	myeloma, multiple	8.6	TP53 MME KIT ESR1 ERBB2 EGFR
497	meningioma, familial	8.6	TP53 SERPINA3 PGR KIT ESR1 ERBB2
498	wilms tumor 1	8.6	TP53 PGR MED12 KIT ESR1 ERBB2
499	tonsil cancer	8.5	TP53 SERPINA3 PGR KRT5 KIT ESR1
500	prostate cancer	8.5	TP53 SERPINA3 PGR MME KRT5 ESR1
501	endometrial cancer	8.5	TP53 SERPINA3 PGR MME KIT ESR1
502	muscular disease	8.4	TP53 SERPINA3 PGR MME KIT ESR1
503	leukemia, acute myeloid	8.4	TP53 SERPINA3 MME KIT ESR1 ERBB2
504	hepatocellular carcinoma	8.3	TP53 SERPINA3 MME KIT ESR1 ERBB2
505	thoracic benign neoplasm	8.1	TP53 SERPINA3 PGR MME MED12 KRT5
506	breast benign neoplasm	8.1	TP53 SERPINA3 PGR MME MED12 KRT5
507	mixed cell type cancer	7.8	TP53 SERPINA3 PGR MME KRT5 KIT

Graphical network of the top 20 diseases related to Breast Malignant Phyllodes Tumor:

Sources

Symptoms & Phenotypes for Breast Malignant Phyllodes Tumor

MGI Mouse Phenotypes related to Breast Malignant Phyllodes Tumor:

⁴⁵ (showing 11, show less)

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	cellular	MP:0005384	10.19	CD34 EGFR ERBB2 ESR1 KIT MED12
2	integument	MP:0010771	10.1	CD34 EGFR ERBB2 ESR1 KIT KRT5
3	embryo	MP:0005380	9.98	EGFR ERBB2 ESR1 KIT MED12 PGR
4	limbs/digits/tail	MP:0005371	9.97	EGFR ERBB2 ESR1 KIT KRT5 MED12
5	craniofacial	MP:0005382	9.95	EGFR ERBB2 KIT KRT5 MED12 TP53
6	digestive/alimentary	MP:0005381	9.93	EGFR ERBB2 ESR1 KIT KRT5 TP53
7	muscle	MP:0005369	9.87	EGFR ERBB2 ESR1 KIT MOCS2 PGR
8	neoplasm	MP:0002006	9.8	CD34 EGFR ERBB2 ESR1 KIT PGR
9	no phenotypic analysis	MP:0003012	9.63	EGFR ESR1 KIT KRT5 PGR TP53
10	normal	MP:0002873	9.5	EGFR ERBB2 ESR1 KIT MED12 PGR
11	skeleton	MP:0005390	9.17	EGFR ERBB2 ESR1 KIT MED12 PGR

Sources

Drugs & Therapeutics for Breast Malignant Phyllodes Tumor

Drugs for Breast Malignant Phyllodes Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 8, show less)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Fluorouracil

Approved

Phase 1

51-21-8

3385

Synonyms:

1004-03-1

1-fluoro-1h-pyrimidine-2,4-dione

1upf

2,4-Dihydroxy-5-fluoropyrimidine

2,4-Dioxo-5-fluoropryimidine

2,4-Dioxo-5-fluoropyrimidine

47576_FLUKA

4921-97-5

5 Fluorouracil

5 Fluorouracil biosyn

5 FU lederle

5 FU Lederle

5 FU medac

5 HU hexal

5 HU Hexal

51-21-8

5-Faracil

5-Fluor-2,4(1H,3H)-pyrimidindion

5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]

5-Fluor-2,4-dihydroxypyrimidin

5-Fluor-2,4-dihydroxypyrimidin [Czech]

5-Fluor-2,4-pyrimidindiol

5-Fluor-2,4-pyrimidindiol [Czech]

5-Fluoracil

5-Fluoracil [German]

5-Fluoracyl

5-fluoro uracil

5-fluoro-1H-pyrimidine-2,4-dione

5-Fluoro-2,4(1H,3H)-pyrimidinedione

5-Fluoro-2,4-pyrimidinedione

5-Fluoropyrimidin-2,4-diol

5-fluoropyrimidine-2,4(1H,3H)-dione

5-Fluoropyrimidine-2,4-dione

5-fluorouracil

5-Fluorouracil

5-Fluorouracil-biosyn

5-Fluoruracil

5-Fluoruracil [German]

5-Fluracil

5-Ftouracyl

5FU

5-FU

5-FU (TN)

5-FU lederle

5-FU Lederle

5-FU medac

5-HU hexal

5-HU Hexal

79108-01-3

AC-11201

AC1L1FTE

AC1Q4N2X

AccuSite

Actino-Hermal

Adrucil

Adrucil (TN)

AI3-25297

AKOS000119162

AKOS003237897

Allergan brand OF fluorouracil

Allergan Brand of Fluorouracil

Arumel

BB_NC-0576

biosyn Brand of Fluorouracil

Biosyn brand OF fluorouracil

BSPBio_002048

C07649

C4H3FN2O2

Carac

Carac (TN)

Carzonal

CCRIS 2582

CHEBI:46345

CHEMBL185

CID3385

Cinco FU

CPD000038082

CPD0-1327

CSP Brand of Fluorouracil

CSP Brand OF fluorouracil

Cytosafe

D005472

D00584

Dakota brand OF fluorouracil

Dakota Brand of Fluorouracil

Dakota, fluorouracile

Dakota, Fluorouracile

DB00544

Dermatech brand OF fluorouracil

Dermatech Brand of Fluorouracil

Dermik brand OF fluorouracil

Dermik Brand of Fluorouracil

DivK1c_000054

Effluderm

Effluderm (free base)

Efudex

Efudix

Efurix

EINECS 200-085-6

EU-0100536

F 6627

F0151

F6627_SIGMA

F8423_SIGMA

Ferrer brand OF fluorouracil

Ferrer Brand of Fluorouracil

Fiverocil

Fluoro Uracil

fluoro Uracile icn

Fluoro Uracile ICN

Fluoroblastin

Fluoroplex

Fluoroplex (TN)

fluorouracil

Fluorouracil

Fluorouracil (JP15/USP/INN)

Fluorouracil [USAN:INN:BAN:JAN]

Fluorouracil gry

Fluorouracil GRY

Fluorouracil mononitrate

Fluorouracil Mononitrate

Fluorouracil monopotassium salt

Fluorouracil Monopotassium Salt

Fluorouracil monosodium salt

Fluorouracil Monosodium Salt

Fluorouracil potassium salt

Fluorouracil Potassium Salt

Fluorouracil teva brand

Fluorouracil Teva Brand

Fluorouracile

Fluoro-uracile

Fluorouracile [DCIT]

Fluorouracile dakota

Fluorouracile Dakota

fluoro-Uracile icn

Fluoro-Uracile ICN

Fluorouracil-gry

Fluorouracil-GRY

Fluorouracilo

Fluoro-uracilo

Fluorouracilo [INN-Spanish]

fluorouracilo Ferrer far

Fluorouracilo Ferrer Far

Fluorouracilum

Fluorouracilum [INN-Latin]

Fluoruracil

Fluouracil

Flurablastin

Fluracedyl

Fluracil

Fluracilum

Fluri

Fluril

Fluro Uracil

Fluroblastin

Flurodex

Flurouracil

Flurox

FT-0082524

Ftoruracil

Gry brand OF fluorouracil

Gry Brand of Fluorouracil

haemato Brand OF fluorouracil

Haemato Brand of Fluorouracil

haemato Fu

Haemato fu

haemato-Fu

Haemato-fu

Hexal brand OF fluorouracil

Hexal Brand of Fluorouracil

HMS1920O18

HMS2090I04

HMS2091F19

HMS500C16

HSDB 3228

I07-0022

ICN brand OF fluorouracil

ICN Brand of Fluorouracil

IDI1_000054

IN1335

inhibits thymilidate synthetase

KBio1_000054

KBio2_001321

KBio2_003889

KBio2_006457

KBio3_001268

KBioGR_001253

KBioSS_001321

Kecimeton

Lopac0_000536

Lopac-F-6627

LS-153

medac Brand of Fluorouracil

Medac brand OF fluorouracil

MLS000069498

MLS002415705

MolPort-000-156-102

MolPort-003-990-447

MolPort-004-758-143

MolPort-004-758-144

MolPort-005-861-486

NCGC00015442-01

NCGC00015442-03

NCGC00015442-10

NCGC00091349-01

NCGC00091349-02

NCGC00091349-03

NCGC00091349-04

NCGC00091349-05

NCGC00091349-07

NCGC00091349-08

nchembio.90-comp3

nchembio809-comp6

NCI60_001652

Neocorp brand OF fluorouracil

Neocorp Brand of Fluorouracil

Neofluor

NINDS_000054

NSC 19893

NSC19893

NSC-19893

Onkofluor

Onkoworks brand OF fluorouracil

Onkoworks Brand of Fluorouracil

Pharmachemie brand OF fluorouracil monosodium salt

Phthoruracil

Phtoruracil

Queroplex

Ribofluor

ribosepharm Brand of Fluorouracil

Ribosepharm brand OF fluorouracil

Riemser brand OF fluorouracil

Riemser Brand of Fluorouracil

Ro 2-9757

Ro-2-9757

Roche brand OF fluorouracil

Roche Brand of Fluorouracil

S1209_Selleck

SAM002264615

SMR000038082

SPBio_000291

Spectrum_000841

SPECTRUM1500305

Spectrum2_000076

Spectrum3_000434

Spectrum4_000557

Spectrum5_000718

STK297802

T5233394

tetratogen

Teva brand OF fluorouracil

Teva Brand of Fluorouracil

Timazin

TL8006093

U 8953

U-8953

Ulup

UNII-U3P01618RT

UPCMLD-DP130

UPCMLD-DP130:001

URF

WLN: T6MVMVJ EF

ZINC00897110

Belinostat

Approved, Investigational

Phase 1

866323-14-0

Parathyroid hormone

Approved, Investigational

Phase 1

9002-64-6

Synonyms:

Parathormone

Parathormone (human recombinant)

Parathyrin

Parathyroid hormone

Parathyroid hormone (1-84) human recombinant

Parathyroid hormone (rDNA)

PTH

PTH(1-84)

rhPTH

rhPTH(1-84)

rPTH

rPTH(1-84)

Immunologic Factors

Phase 1

Histone Deacetylase Inhibitors

Phase 1

Antimetabolites

Phase 1

Androgens

Phase 1

Immunosuppressive Agents

Phase 1

Interventional clinical trials:

(showing 3, show less)

#	Name	Status	NCT ID	Phase	Drugs
1	A Phase I Safety, Pharmacodynamic, Anti-Tumor Activity, and Pharmacokinetic Study of PXD101 Alone and in Combination With 5-Fluorouracil in Patients With Advanced Solid Tumors	Completed	NCT00413322	Phase 1	belinostat;5-Fluorouracil (5-FU)
2	A Prospective Study of Adjuvant Radiation Therapy After Resection of Borderline and Malignant Phyllodes Tumors	Completed	NCT00003404
3	A Prospective Study of Partial Breast Adjuvant Radiation Therapy After Resection of Borderline and Malignant Phyllodes Tumors	Recruiting	NCT01089374

Search NIH Clinical Center for Breast Malignant Phyllodes Tumor

Sources

Genetic Tests for Breast Malignant Phyllodes Tumor

Sources

Anatomical Context for Breast Malignant Phyllodes Tumor

MalaCards organs/tissues related to Breast Malignant Phyllodes Tumor:

⁴⁰

Breast, Prostate, Lung, Bone, Liver, Skin, Thymus

Sources

Publications for Breast Malignant Phyllodes Tumor

Articles related to Breast Malignant Phyllodes Tumor:

(showing 218, show less)

#	Title	Authors	PMID	Year
1	Lacrimal Sac Metastasis from Phyllodes Tumor of the Breast. ⁶¹	Kim SH...Kang SM	32037753	2020
2	Phyllodes Tumor of the Breast: A Clinicopathological Evaluation of 55 Cases. ⁶¹	Hasdemir S...Gokgoz MS	31912011	2020
3	Radiotherapy with apatinib for recurrence of malignant phyllodes tumor of the breast: A case report. ⁶¹	Wu H...Wang H	32011486	2020
4	The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex vivo study. ⁶¹	Urbaniak A...Chambers TC	31612021	2019
5	A rare case of a malignant phyllodes tumor of the breast associated with secretion of beta-human chorionic gonadotropin. ⁶¹	Andring L...Deraniyagala R	31192485	2019
6	Giant phyllodes tumor of the breast. ⁶¹	Pascarella S...Reilly K	31486153	2019
7	Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report. ⁶¹	Kuo CY...Tu SH	31351458	2019
8	Cytologic diagnosis of metastatic malignant phyllodes tumor of the breast in pleural effusion. ⁶¹	Li JJX...Tse GM	30829462	2019
9	Malignant phyllodes tumor of the breast with liposarcomatous differentiation: A case report with imaging findings. ⁶¹	Kim JH...Lee JY	30834064	2019
10	Phyllodes tumors of the breast. The treatment results for 340 patients from a single cancer centre. ⁶¹	Mitus JW...Wysocki W	30521986	2019
11	Not Every Fat-Containing Lesion on Mammogram is a Benign Finding: Case Report and Review of Breast Malignant Phyllodes Tumor with Heterologous Liposarcomatous Differentiation. ⁶¹	Soni N...Policeni F	31448161	2019
12	Phyllodes tumor of the breast: diagnosis, management and outcome during a 10-year experience. ⁶¹	Ditsatham C...Chongruksut W	31695485	2019
13	Recurrent borderline phyllodes tumor of the breast submitted to mastectomy and immediate reconstruction: Case report. ⁶¹	Garlet BB...Krahe FD	31195364	2019
14	Phyllodes tumor of the breast with nipple discharge: A case report. ⁶¹	Jing P...Yang X	30593154	2018
15	Percutaneous removal of benign phyllodes tumor of the breast: An alternative to surgery. ⁶¹	Grana Lopez L...Villares Armas A	30251456	2018
16	Radiopathological characteristics and outcomes of phyllodes tumor of the breast in Malaysian women. ⁶¹	Abdul Hamid S...Taib NAM	30075507	2018
17	Metastatic giant malignant phyllodes tumor of the breast. ⁶¹	Sanchez AM...Masetti R	29139587	2018
18	Phyllodes Tumor of the Breast: Ultrasound-Pathology Correlation. ⁶¹	Kalambo M...Whitman GJ	29412020	2018
19	Early stage malignant phyllodes tumor case report. ⁶¹	Wolbert T...Legenza M	29247967	2018
20	Malignant Phyllodes Tumor of the Breast with Metastasis to the Pancreas: A Case Report and Review of Literature. ⁶¹	Amir RA...Sheikh SS	30050709	2018
21	Phyllodes tumor masquerading as a fungating breast mass. ⁶¹	Bruce NR...Henry-Tillman R	29250309	2017
22	Recurrent malignant phyllodes tumor of the breast: A case report. ⁶¹	Wang Q...Lei Y	29245318	2017
23	A rare presentation of malignant phyllodes tumor with bloody nipple discharge-report of a case. ⁶¹	Chen WH	28861384	2017
24	Radiation therapy for malignant phyllodes tumor of the breast: An analysis of SEER data. ⁶¹	Kim YJ...Kim K	28013032	2017
25	Giant phyllodes tumor of the breast with diffuse myxoid changes in an adolescent girl: a case report. ⁶¹	Lee JY	28458828	2017
26	Multiple metastatic malignant phyllodes tumor of the breast with tonsillar metastasis: a case report. ⁶¹	Sera T...Ohira M	28103951	2017
27	A giant phyllodes tumor of the breast causing severe disfigurement. A case report. ⁶¹	Franceschini G...Masetti R	28406095	2017
28	Clinicopathology and treatment of a giant malignant phyllodes tumor of the breast: A case report and literature review. ⁶¹	Warner WA...Maharaj R	29121581	2017
29	Phyllodes Tumor of the Breast: Analysis of 48 Patients. ⁶¹	Kilic MO...Daglar G	28331755	2016
30	A Giant Phyllodes Tumor of the Breast. ⁶¹	Schillebeeckx C...Bronckaers M	27746880	2016
31	A Case of Giant Borderline Phyllodes Tumor of the Breast Associated with Hypoglycemia. ⁶¹	Saito Y...Tokuda Y	27628602	2016
32	Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast. ⁶¹	Takizawa K...Oda Y	27137988	2016
33	Breast malignant phyllodes tumor with rare pelvic metastases and long-term overall survival: A case report and literature review. ⁶¹	Shan J...Wang X	27661051	2016
34	Giant malignant phyllodes tumor of the breast: A rare case report and literature review. ⁶¹	Liu M...Dong L	27347111	2016
35	Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates. ⁶¹	Zhang Y...Kleer CG	27362571	2016
36	Benign Phyllodes Tumor of the Breast Diagnosed After Ultrasound-Guided Vacuum-Assisted Biopsy: Surgical Excision or Wait-and-Watch? ⁶¹	Ouyang Q...Su F	26577125	2016
37	Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast. ⁶¹	Mitus JW...Kulpa J	26464157	2016
38	The largest and neglected giant phyllodes tumor of the breast-A case report and literature review. ⁶¹	Islam S...Naraynsingh V	27475116	2016
39	Coexistence of malignant phyllodes tumor and her2-positive locally advanced breast cancer in distinct breasts: A case report. ⁶¹	Sato T...Sakai T	26773878	2016
40	"Ruptured" malignant phyllodes tumor of the breast: a case report. ⁶¹	Ditsatham C...Wongmaneerung P	26952179	2016
41	Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast. ⁶¹	Gatalica Z...Pockaj B	26625196	2016
42	Phyllodes Tumor of the Breast: 307 Treated Cases, the Largest Mexican Experience at a Single Breast Disease Institution. ⁶¹	Ruvalcaba-Limon E...Rodriguez-Cuevas S	28855932	2016
43	Metastatic Malignant Phyllodes Tumor of the Breast: An Aggressive Disease-Analysis of 7 Cases. ⁶¹	Ramakant P...Paul MJ	27065662	2015
44	Malignant phyllodes tumor of the breast with isolated intracranial metastases: A report. ⁶¹	Jhawar SS...Grewal SS	26588634	2015
45	[Pulmonary Metastasis from a Phyllodes Tumor of the Breast Developing Sixteen Years after Initial Surgery]. ⁶¹	Chang SS...Takabatake D	26555915	2015
46	Pleomorphic liposarcoma arising in a malignant phyllodes tumor of breast: A rare occurrence. ⁶¹	Sancheti SM...Ahmed R	26881623	2015
47	Phyllodes tumor of the breast: a clinic-pathologic study of 77 cases in a Hispanic cohort. ⁶¹	Ossa CA...Jaramillo R	26600624	2015
48	Phyllodes Tumor of the Breast With Malignant Melanoma Component: A Case Report. ⁶¹	Vergine M...Taylor MR	26113664	2015
49	A Rare Case of Breast Malignant Phyllodes Tumor With Metastases to the Kidney: Case Report. ⁶¹	Karczmarek-Borowska B...Gradalska-Lampart M	26287414	2015
50	Identification of clinically relevant alterations in phyllodes tumor of the breast by amplicon-based next-generation sequencing. ⁶¹	Tsang JY...Tse GM	25900796	2015
51	Large Malignant Phyllodes Tumor of the Breast with Metastases to the Lungs. ⁶¹	Augustyn A...Wooldridge RD	26266007	2015
52	[MRI features of phyllodes tumor of the breast and the pathological study]. ⁶¹	Hou W...Yu X	25931218	2015
53	Benign phyllodes tumor of the breast recurring as a malignant phyllodes tumor and spindle cell metaplastic carcinoma. ⁶¹	Muller KE...Marotti JD	25476122	2015
54	Malignant phyllodes tumor of the breast with liposarcomatous differentiation and intraductal hyperplasia. ⁶¹	Ayadi-Kaddour A...El Mezni F	25061020	2015
55	Phyllodes tumor of the breast metastasizing to the vulva. ⁶¹	Ajenifuja OK...Lele S	25960902	2015
56	Phyllodes tumor: review of key imaging characteristics. ⁶¹	Plaza MJ...Esserman LE	25792027	2015
57	How to approach phyllodes tumors of the breast? ⁶¹	Acar T...Tatar F	26668526	2015
58	Synchronous bilateral primary breast malignant phyllodes tumor and carcinoma of the breast with Paget's disease: a case report and review of the literature. ⁶¹	Zhao H...Zeng F	26770378	2015
59	Malignant phyllodes tumor of the breast: treatment and prognosis. ⁶¹	Mitus J...Skotnicki P	25227987	2014
60	[The case of a giant malignant phyllodes tumor of the breast]. ⁶¹	Ueno S...Karigome K	25731379	2014
61	Malignant phyllodes tumor of the breast: a case study. ⁶¹	Keim-Malpass J...Showalter SL	25253115	2014
62	In Situ Ductal Carcinoma Arising in Benign Phyllodes Tumor in 19-Year Old Patient: A Case Report. ⁶¹	Colakoglu MK...Camlibel M	28331678	2014
63	Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center. ⁶¹	Wei J...Shi YX	25104281	2014
64	Phyllodes tumor of the breast: role of Axl and ST6GalNAcII in the development of mammary phyllodes tumors. ⁶¹	Ren D...Zhao Y	24961352	2014
65	Giant abdominal mass: a unique form of metastatic malignant phyllodes tumor of the breast. ⁶¹	Friedman G...Reeves ME	24887716	2014
66	Malignant phyllodes tumor of the breast presenting with hypoglycemia: a case report and literature review. ⁶¹	Pacioles T...Dhaliwal R	25525388	2014
67	Analysis of patients with phyllodes tumor of the breast. ⁶¹	Atalay C...Celebioglu S	25931913	2014
68	Phyllodes tumor metastasis to the tonsil with synchronous undifferentiated carcinoma. ⁶¹	Sano R...Nakashima T	24747756	2014
69	Changes in the clinical characteristics, treatment options, and therapy outcomes in patients with phyllodes tumor of the breast during 55 years of experience. ⁶¹	Mitus JW...Wysocki WM	24356679	2013
70	A young woman with a giant breast fibrosarcoma: a case report. ⁶¹	Jiao Q...Zheng L	24255792	2013
71	An 11 kg Phyllodes tumor of the breast in combination with other multiple chronic diseases: Case report and review of the literature. ⁶¹	Zhao Z...Wang J	23946794	2013
72	Phyllodes tumor showing intraductal growth. ⁶¹	Makidono A...Suzuki K	20490731	2013
73	[Phyllodes tumor of the breast: clinicopathologic analysis of 22 cases]. ⁶¹	Velazquez-Dohorn M...Medina-Franco H	23877808	2013
74	Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis. ⁶¹	Sawalhi S...Al-Shatti M	23563006	2013
75	Adrenal metastasis of a phyllodes tumor of the breast: Case report and review of the literature. ⁶¹	Collin Y...Sideris L	23792482	2013
76	[Usefulness of endoscopic resection for phyllodes tumor of the breast]. ⁶¹	Sakurai K...Amano S	23267964	2012
77	Factors associated with phyllodes tumor of the breast after core needle biopsy identifies fibroepithelial neoplasm. ⁶¹	Gould DJ...Silberfein EJ	22524977	2012
78	Malignant Phyllodes Tumor of the Breast Metastasizing to the Vulva: (18)F-FDG PET-CT Demonstrating Rare Metastasis from a Rare Tumor. ⁶¹	Khangembam BC...Kumar R	24900068	2012
79	Trichoblastic sarcoma with osteosarcomatous differentiation: evolution of one lesion with 3 histologic appearances over a 3-year period. ⁶¹	Hung T...Crawford RI	22688391	2012
80	Jejunal intussusception due to malignant phyllodes tumor of the breast. ⁶¹	Bilen MA...Cyprus GS	22381472	2012
81	Long-term follow-up result of benign phyllodes tumor of the breast diagnosed and excised by ultrasound-guided vacuum-assisted breast biopsy. ⁶¹	Park HL...Lee YH	22807941	2012
82	Malignant phyllodes tumors of the breast: a study in clinical practice. ⁶¹	Majeski J...Stroud J	23102073	2012
83	Phyllodes tumor of the breast: role of CD10 in predicting metastasis. ⁶¹	Al-Masri M...Al-Shatti M	22006372	2012
84	[Malignant phyllodes tumor of the breast with liposarcomatous differentiation. Solution to case 40]. ⁶¹	Nieto Parra JA...Fal Ordonez MA	21733534	2012
85	Anemia and jejunal intussusception: An unusual presentation for a metastatic phyllodes breast tumor. ⁶¹	Schechet SA...Scott BG	22288047	2012
86	[Malignant phyllodes tumor of the breast after Hodgkin's disease]. ⁶¹	Mohamed el H...Tijani el H	23396310	2012
87	Phyllodes tumor of the breast. ⁶¹	Korpanty G...McCaffrey J	20890734	2011
88	Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors. ⁶¹	Abe M...Iwase T	22121516	2011
89	Malignant phyllodes tumor of the breast: case report. ⁶¹	Souza JA...Chojniak R	22012279	2011
90	Recurrent phyllodes tumor of the breast: defining the role for skin-sparing mastectomy and autologous reconstruction. ⁶¹	Atalla MA...Cham A	21432750	2011
91	Giant phyllodes tumor of the breast: Consequence of carelessness. ⁶¹	Zayen S...Guermazi M	20843180	2011
92	CD34, CD117, and Ki-67 expression in phyllodes tumor of the breast: an immunohistochemical study of 33 cases. ⁶¹	Noronha Y...Wang J	21087983	2011
93	De novo phyllodes tumor in an adolescent female after liver transplantation. ⁶¹	Cheng F...Wang XH	19691525	2011
94	Difficulties in diagnosing and treating phyllodes tumor of the breast--case report. ⁶¹	Uchman P...Sajdak S	21446340	2011
95	[Long-term results of surgical therapy for phyllodes tumor of the breast]. ⁶¹	Sakurai K...Amano S	21224712	2010
96	[Malignant phyllodes tumor of the breast with lymph node metastases shown by FDG PET-CT]. ⁶¹	Santiago Chinchilla A...Llamas Elvira JM	20692076	2010
97	Extent of surgery in the management of phyllodes tumor of the breast: a retrospective multicenter study from India. ⁶¹	Verma S...Mohan N	21358091	2010
98	Pulmonary artery obstruction due to a metastatic malignant phyllodes tumor of the breast. ⁶¹	Nakatsu T...Kitaoka M	20703865	2010
99	A case of a giant phyllodes tumor of the breast with hypoglycemia caused by high-molecular-weight insulin-like growth factor II. ⁶¹	Hino N...Tsuyuguchi M	19259766	2010
100	Synchronous Bilateral Benign Phyllodes Tumor of the Breast in a 32-year-old Woman. ⁶¹	Trabelsi A...Mokni M	29147179	2010
101	Phyllodes tumor of the breast: an update. ⁶¹	Tse GM...Shi HJ	19434472	2010
102	Phyllodes tumor of the breast; a case series. ⁶¹	Akin M...Tekin E	20568416	2010
103	Loss of SDHB and NF1 genes in a malignant phyllodes tumor of the breast as detected by oligo-array comparative genomic hybridization. ⁶¹	Lee J...Li S	20082856	2010
104	Beta-human chorionic gonadotropin production associated with phyllodes tumor of the breast: an unusual paraneoplastic phenomenon. ⁶¹	Reisenbichler ES...Hameed O	19624411	2009
105	A phyllodes tumor in a child. ⁶¹	Pistolese CA...Simonetti G	19539191	2009
106	Magnetic Resonance Imaging of a Benign Phyllodes Tumor of the Breast. ⁶¹	Balaji R...Ramachandran KN	20847879	2009
107	Surgical treatment of giant recurrent breast phyllodes tumor. ⁶¹	Li X...Li R	19107368	2008
108	Malignant phyllodes tumor of the breast: local control rates with surgery alone. ⁶¹	Pezner RD...Paz IB	18234448	2008
109	Benign phyllodes tumor of the breast with intracytoplasmic inclusion bodies identical to infantile digital fibromatosis. ⁶¹	Dey D...Singer S	18266786	2008
110	Giant borderline phyllodes tumor of the breast. ⁶¹	Silvestris N...Pezzella G	18312468	2008
111	Phyllodes tumor of the breast. ⁶¹	Belkacemi Y...Ozsahin M	17931796	2008
112	Phyllodes tumor of the breast in an adolescent girl. ⁶¹	Cecen E...Canda T	18231958	2008
113	Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin. ⁶¹	Taira N...Teramoto N	17932112	2007
114	Association of the BRCA1 missense variant R1699W with a malignant phyllodes tumor of the breast. ⁶¹	Rhiem K...Schmutzler RK	17574969	2007
115	Hypoglycemic coma secondary to big insulin-like growth factor II secretion by a giant phyllodes tumor of the breast. ⁶¹	Aguiar Bujanda D...Le Bouc Y	17319862	2007
116	[Malignant phyllodes tumor of the breast with osteoclast-like giant cells: a case report]. ⁶¹	Fernandez-Aguilar S...Noel JC	17568357	2007
117	Phyllodes tumor of the breast: correlation between MR findings and histologic grade. ⁶¹	Yabuuchi H...Honda H	17032912	2006
118	Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. ⁶¹	Macdonald OK...Gaffney DK	16998937	2006
119	Malignant phyllodes tumor with heterologous liposarcomatous differentiation and tubular adenoma-like epithelial component. ⁶¹	Uriev L...Ben-Dor D	17003843	2006
120	Phyllodes tumor of the breast: the challenge persists. ⁶¹	Cheng SP...Liu CL	16865317	2006
121	Phyllodes tumor with osteosarcomatous differentiation: a comparative immunohistochemical study between epithelial and mesenchymal cells. ⁶¹	Ribeiro-Silva A...Zucoloto S	17036527	2006
122	Prognostic factors of phyllodes tumor of the breast. ⁶¹	Roa JC...Roa I	16704494	2006
123	A case of noninvasive ductal carcinoma arising in malignant phyllodes tumor. ⁶¹	Nomura M...Ohshima M	16518067	2006
124	Radical surgical resection of a giant pleural metastasis of a malignant phyllodes tumor of the breast. ⁶¹	Filosso PL...Oliaro A	16308019	2005
125	[Phyllodes tumor of the breast: analysis of 8 patients]. ⁶¹	Sabban F...Vinatier D	16012385	2005
126	Preoperative embolization of vascular phyllodes tumor of the breast. ⁶¹	Leung JW...Sickles EA	15727999	2005
127	Phyllodes tumor of the breast: magnetic resonance imaging findings and surgical treatment. ⁶¹	Franceschini G...Picciocchi A	15730463	2005
128	A case of phyllodes tumor of the breast with a lesion mimicking fibroadenoma. ⁶¹	Tomimaru Y...Koyama H	16286914	2005
129	Phyllodes tumor of the seminal vesicle: case report and literature review. ⁶¹	Son HJ...Chung MJ	15598315	2004
130	Cytogenetic findings in phyllodes tumor and fibroadenomas of the breast. ⁶¹	Barbosa ML...Cavalli IJ	15474152	2004
131	Phyllodes tumor of the breast: local recurrence versus metastatic capacity. ⁶¹	Carter BA...Page DL	15343504	2004
132	Scintimammographic findings of phyllodes tumor of the breast in a double-phase study with Tc-99m (V)DMSA and Tc-99m MIBI: a case report. ⁶¹	Papantoniou V...Zerva C	15342672	2004
133	Benign phyllodes tumor associated with Maffucci's syndrome. ⁶¹	Fernandez-Aguilar S...Noel JC	15177431	2004
134	Magnetic resonance imaging of benign phyllodes tumors of the breast. ⁶¹	Kinoshita T...Kubochi K	15125750	2004
135	Phyllodes tumor of the breast: case series of 40 patients. ⁶¹	Eroglu E...Eroglu F	15053081	2004
136	Prognostic factors in phyllodes tumor of the breast: are immunohistochemical biomarkers useful? ⁶¹	Chu JS	15077882	2004
137	Expression of p53 protein and Ki-67 antigen in phyllodes tumor of the breast. ⁶¹	Chan YJ...Fan CC	15077883	2004
138	Massive infarction of a recurrent phyllodes tumor of the breast: MRI-findings. ⁶¹	Verslegers I...Parizel PM	15055329	2004
139	Malignant phyllodes tumor of the breast: review of the literature and case report of stromal overgrowth. ⁶¹	Guerrero MA...Grau AM	12689668	2003
140	Invasive lobular carcinoma arising in phyllodes tumor of the breast. ⁶¹	Kodama T...Okada Y	12743817	2003
141	Hypertrophic osteoarthropathy associated with metastatic phyllodes tumor. ⁶¹	Landrum ML...Ornstein DL	12714885	2003
142	Malignant phyllodes tumor of the breast metastatic to the parotid gland diagnosed by fine needle aspiration biopsy. A case report. ⁶¹	Zhang JZ...Gu M	12685197	2003
143	Radiologic-pathologic conferences of the University of Texas M.D. Anderson Cancer Center. Phyllodes tumor of the breast. ⁶¹	Lifshitz OH...Yang WT	12540427	2003
144	Cystosarcoma phyllodes in a 13-year-old Muslim girl treated with conservative surgery: a case report. ⁶¹	Galazios G...Sivridis E	12691328	2003
145	Malignant phyllodes tumor of the breast with predominant chondrosarcomatous differentiation. ⁶¹	Vera-Sempere F...Garcia-Martinez A	14989497	2003
146	MRI in phyllodes tumor of the breast. Case reports. ⁶¹	Costantini M...Belli P	12696294	2002
147	[Image of the month. Phyllodes tumor of the breast]. ⁶¹	Defechereux T...Meurisse M	12481463	2002
148	Clinicopathological study on phyllodes tumor of the breast. ⁶¹	Shi F...Breast Phyllodes Tumor Study Group	12475436	2002
149	Phyllodes tumor of the breast. A cytomorphologic approach based on evaluation of epithelial cluster architecture. ⁶¹	Shimizu K...Korematsu M	11917581	2002
150	Malignant phyllodes tumor with pleomorphic liposarcomatous stroma diagnosed by fine needle aspiration cytology: a case report. ⁶¹	Vera-Alvarez J...Perez-Ruiz J	11843559	2002
151	Complex karyotype in a low grade phyllodes tumor of the breast. ⁶¹	Ladesich J...Davoren B	11850078	2002
152	Clinical Analysis of Phyllodes Tumor of the Breast. ⁶¹	Han SH...Park HG	26680822	2001
153	Phyllodes tumor of the breast with actin inclusions in stromal cells: diagnosis by fine-needle aspiration cytology. ⁶¹	Ortega E...Segui J	11477716	2001
154	Unusual clinical presentation of a rare case of phyllodes tumor of the breast in an adolescent girl. ⁶¹	Martino A...Amici G	11381432	2001
155	Malignant phyllodes tumor of the breast with expression of osteonectin and vinculin. ⁶¹	Kuroda N...Enzan H	11350610	2001
156	A case of malignant phyllodes tumor of the breast with osteosarcomatous features. ⁶¹	Matsuo K...Nanasawa T	11180771	2001
157	Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases. ⁶¹	Niezabitowski A...Markiewicz D	11245343	2001
158	CD34, CD117, and actin expression in phyllodes tumor of the breast. ⁶¹	Chen CM...Harn HJ	11104647	2000
159	Phyllodes tumor of the breast: EGFR family expression and relation to clinicopathological features. ⁶¹	Suo Z...Nesland JM	11206334	2000
160	[Phyllodes tumor of the breast. Personal contribution of 21 cases]. ⁶¹	Gabriele R...Conte M	11227146	2000
161	Phyllodes tumor of the breast. A cytohistologic study of 80 cases. ⁶¹	Bhattarai S...Verma K	11015981	2000
162	Malignant phyllodes tumor of the breast metastasizing to the pancreas: case report. ⁶¹	Yu PC...Chen MF	11039254	2000
163	[Primary breast tumor and malignant phyllodes tumor of the breast-- two rare cases demonstrated by technetium 99m scintimammography]. ⁶¹	Pappo I...Orda R	10979402	2000
164	A Case of Phyllodes Tumor with Bloody Nipple Discharge in Juvenile Patient. ⁶¹	Tagaya N...Shimizu K	11091717	1999
165	Phyllodes tumor of the breast. ⁶¹	Mazy S...Van Reepinghen P	11155875	1999
166	[Phyllodes tumor of the breast with cystic portion: MR imaging with histopathological correlation]. ⁶¹	Kitamura K...Hanai J	10388308	1999
167	Phyllodes tumors of the breast. ⁶¹	Jorge Blanco A...Martinez Cendejas E	10101663	1999
168	[Pulmonary metastatic malignant phyllodes tumor showing multiple thin walled cavities]. ⁶¹	Yagishita M...Kobashi Y	10087879	1999
169	Phyllodes Tumor of the Breast with a Grossly Malignant Appearance: A Case Report. ⁶¹	Miyaguni T...Muto Y	11091650	1998
170	The extent of surgery and prognosis of patients with phyllodes tumor of the breast. ⁶¹	Zissis C...Vassilopoulos PP	9598867	1998
171	Malignant phyllodes tumor of the breast with hypoglycemia: report of a case. ⁶¹	Kataoka T...Nomura S	9657015	1998
172	Is there a role for radiation therapy for the management of phyllodes tumor of the breast? ⁶¹	Powell S	9885946	1998
173	Adjuvant radiotherapy for phyllodes tumor of breast. ⁶¹	Chaney AW...Zagars GK	9885942	1998
174	Tc-99m sestamibi and Tc-99m HMDP uptake in a malignant phyllodes tumor of the breast. ⁶¹	Ohta H...Irie K	9262903	1997
175	Dynamic MR appearance of benign phyllodes tumor of the breast in a 20-year-old woman. ⁶¹	Ogawa Y...Toki T	9311043	1997
176	Malignant cystosarcoma phyllodes tumor of the breast mainly composed of chondrosarcoma: a case report. ⁶¹	Iihara K...Sato A	9065591	1997
177	Technetium-99m-sestamibi scintimammography of benign and malignant phyllodes tumors. ⁶¹	Ohta H...Shintaku M	9095321	1997
178	Immunohistochemical profile of phyllodes tumors of the breast. ⁶¹	Singh Y...Tsubura A	21594434	1996
179	Benign phyllodes tumor of the breast: MR imaging features. ⁶¹	Farria DM...Bassett LW	8659370	1996
180	Phyllodes Tumor of the Breast: Pathology, Histogenesis, Diagnosis, and Treatment. ⁶¹	Noguchi S...Wada A	11091559	1996
181	[Phyllodes tumor of the breast: diagnostic and therapeutic problems]. ⁶¹	Gangi S...Basile F	8929037	1996
182	The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. ⁶¹	Reinfuss M...Smolak K	8608483	1996
183	No rearrangement of the CHOP and TLS/FUS genes in two cases of phyllodes tumor of the breast. ⁶¹	Birdsall SH...Cooper CS	8646752	1996
184	Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis. ⁶¹	Noguchi S...Koyama H	8625047	1995
185	Additional copies of 1q in sequential samples from a phyllodes tumor of the breast. ⁶¹	Birdsall SH...Shipley JM	7553578	1995
186	Is i(1)(q10) a chromosome marker in phyllodes tumor of the breast? ⁶¹	Dal Cin P...Van den Berghe H	7553592	1995
187	Clinicopathologic study of phyllodes tumor of the breast. ⁶¹	Chu JS...Hsu HC	7613256	1995
188	A Malignant Phyllodes Tumor of the Breast in a 6-Year Old Girl. ⁶¹	Sasa M...Monden Y	11091535	1995
189	Phyllodes tumor of the breast. ⁶¹	Reinfuss M...Stelmach A	7839306	1995
190	Flow Cytometric Analysis to Assess the Malignant Potential of Phyllodes Tumor. ⁶¹	Tomita S...Nagamine Y	11091522	1994
191	Phyllodes tumor of the breast containing the intracytoplasmic inclusion bodies identical with infantile digital fibromatosis. ⁶¹	Hiraoka N...Hata J	8172324	1994
192	Phyllodes tumor of the breast. An immunohistochemical study of 28 cases with special attention to the role of myofibroblasts. ⁶¹	Aranda FI...Lopez JI	7991467	1994
193	Patterns of p53 expression in phyllodes tumors of the breast--an immunohistochemical study. ⁶¹	Kim CJ...Kim WH	8305139	1993
194	Clonal analysis of fibroadenoma and phyllodes tumor of the breast. ⁶¹	Noguchi S...Koyama H	8395336	1993
195	Phyllodes tumor of the breast: problems of differential diagnosis and therapeutic approach from an analysis of 17 cases. ⁶¹	Modena S...Iannucci A	8382173	1993
196	99mTc-HMDP accumulation in a phyllodes tumor of the breast, a case report. ⁶¹	Ohta H...Yamamoto K	8384869	1993
197	Phyllodes tumor of the breast: a multicenter series of 59 cases. Coordinating Center and Writing Committee of FONCAM (National Task Force for Breast Cancer), Italy. ⁶¹	Ciatto S...Cardona G	1335886	1992
198	[Diagnosis, prognosis and therapy of phyllodes tumor of the breast]. ⁶¹	Mezi S...Modesti M	1329905	1992
199	[Phyllodes tumor of the breast]. ⁶¹	Rossi M...Tassinari G	1331870	1992
200	Apocrine metaplasia in phyllodes tumor of the breast. ⁶¹	Insabato L	2171287	1990
201	Apocrine and bony metaplasia in a borderline phyllodes tumor of the breast. ⁶¹	Insabato L...Ferrara G	2171288	1990
202	Phyllodes tumor of the breast: a clinicopathologic study of 34 cases. ⁶¹	Kario K...Kitazawa S	2166186	1990
203	Small sized phyllodes tumor of the breast. ⁶¹	Bartoli C...Clemente C	2161352	1990
204	[A case of giant phyllodes tumor with special reference to its process of enlargement]. ⁶¹	Takaori K...Shizuki K	1966666	1990
205	[Phyllodes tumor of the breast (cystosarcoma phyllodes) (apropos 3 cases)]. ⁶¹	Genoni E...Ciprandi G	1963818	1990
206	[Phyllodes tumor of the breast]. ⁶¹	Santangelo A...Esposito F	2552357	1989
207	[Phyllodes tumor of the breast with stromal metaplasia]. ⁶¹	Mazanec K	2834111	1988
208	Multinucleated giant cells in malignant phyllodes tumor of the breast. ⁶¹	Dworak O...Schmutzler RK	3179069	1988
209	[Phyllodes tumor of the breast in an 11-year-old child]. ⁶¹	Blanckaert D...Laurent JC	2849086	1988
210	Intraductal carcinoma within a phyllodes tumor of the breast: a case report. ⁶¹	Grove A...Deibjerg Kristensen L	3010519	1986
211	[Primary retroperitoneal tumor (Dominici's mesenchymoma) associated with leiomyoma of the sigmoid, a phyllodes tumor of the breast and uterine myomatosis]. ⁶¹	de Juan Martin M...Maceiras Quintian F	6093207	1984
212	[Anatomical and clinical deliberations on the phyllodes tumor of the breast]. ⁶¹	Gavrilescu C...Tarabuta-Cordun G	184625	1976
213	[Phyllodes tumor of the breast. Anatomo-clinical considerations and case reports]. ⁶¹	Lise M...Pedrazzoli S	4320392	1969
214	[Phyllodes tumor of the breast]. ⁶¹	KROKOWICZ A	14459798	1962
215	[Malignant form of Mueller's phyllodes tumor of the breast]. ⁶¹	MARCONI G...CORRADINI E	13932894	1961
216	[Clinical aspects of phyllodes tumor of the breast]. ⁶¹	WOJNEROWICZ C	13623443	1958
217	[Case of phyllodes tumor of the breast]. ⁶¹	DOZIO G	13453797	1957
218	[A case of phyllodes tumor of the breast in a 15-year-old girl]. ⁶¹	MANCINI M	13298041	1955

Sources

Genes for Breast Malignant Phyllodes Tumor

Genes related to Breast Malignant Phyllodes Tumor (0 elite genes):

(showing 12, show less)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	SERPINA3	Serpin Family A Member 3	Protein Coding	7.13	DISEASES inferred ¹⁵ ¹⁵
2	MED12	Mediator Complex Subunit 12	Protein Coding	7.09	DISEASES inferred ¹⁵
3	PGR	Progesterone Receptor	Protein Coding	6.37	DISEASES inferred ¹⁵
4	ERBB2	Erb-B2 Receptor Tyrosine Kinase 2	Protein Coding	6.19	DISEASES inferred ¹⁵
5	ESR1	Estrogen Receptor 1	Protein Coding	6.18	DISEASES inferred ¹⁵
6	TP53	Tumor Protein P53	Protein Coding	6.12	DISEASES inferred ¹⁵
7	CD34	CD34 Molecule	Protein Coding	6.11	DISEASES inferred ¹⁵
8	KRT5	Keratin 5	Protein Coding	6.06	DISEASES inferred ¹⁵
9	MME	Membrane Metalloendopeptidase	Protein Coding	5.83	DISEASES inferred ¹⁵
10	KIT	KIT Proto-Oncogene, Receptor Tyrosine Kinase	Protein Coding	5.72	DISEASES inferred ¹⁵
11	MOCS2	Molybdenum Cofactor Synthesis 2	Protein Coding	5.62	DISEASES inferred ¹⁵
12	EGFR	Epidermal Growth Factor Receptor	Protein Coding	5.39	DISEASES inferred ¹⁵

Sources

Variations for Breast Malignant Phyllodes Tumor

Sources

Expression for Breast Malignant Phyllodes Tumor

Search GEO for disease gene expression data for Breast Malignant Phyllodes Tumor.

Sources

Pathways for Breast Malignant Phyllodes Tumor

Pathways related to Breast Malignant Phyllodes Tumor according to GeneCards Suite gene sharing:

(showing 18, show less)

#	Super pathways	Score	Top Affiliating Genes
1	MAPK signaling pathway ³⁶ ¹	12.54	TP53 KIT ERBB2 EGFR
2	Pathways in cancer ³⁶	12.53	TP53 KIT ESR1 ERBB2 EGFR
3	Downstream signaling events of B Cell Receptor (BCR) ⁶⁵ Show member pathways Activation of RAS in B cells ⁶⁵ Signaling by the B Cell Receptor (BCR) ⁶⁵	12.49	TP53 KIT ERBB2 EGFR
4	Glioma ³⁶ Show member pathways Endocrine resistance ³⁶ Melanoma ³⁶ Non-small cell lung cancer ³⁶ Signaling Pathways in Glioblastoma ¹	12.43	TP53 ESR1 ERBB2 EGFR
5	Gastric cancer ³⁶ Show member pathways Breast cancer ³⁶ Hepatocellular carcinoma ³⁶	12.1	TP53 PGR KIT ESR1 ERBB2 EGFR
6	Integrated Breast Cancer Pathway ¹	11.93	TP53 ESR1 EGFR
7	Proteoglycans in cancer ³⁶	11.93	TP53 ESR1 ERBB2 EGFR
8	Tyrosine Kinases / Adaptors ⁴	11.9	KIT ERBB2 EGFR
9	MAPK Pathway ⁷⁰ Show member pathways Toll-like Receptor Pathway ⁷⁰	11.79	TP53 ERBB2 EGFR
10	Thyroid hormone signaling pathway ³⁶	11.76	TP53 MED12 ESR1
11	Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers ⁶⁴	11.74	MME KIT CD34
12	Hematopoietic cell lineage ³⁶	11.65	MME KIT CD34
13	Signaling by ERBB4 ⁶⁵ Show member pathways Downregulation of ERBB4 signaling ⁶⁵ ErbB4 signaling events ¹ Nuclear signaling by ERBB4 ⁶⁵	11.59	PGR ESR1 ERBB2 EGFR
14	Dendritic Cells Developmental Lineage Pathway ⁶⁴	11.5	MME KIT CD34
15	Bladder cancer ³⁶ ¹	11.47	TP53 ERBB2 EGFR
16	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors ⁶⁵ Show member pathways Activation of the TFAP2 (AP-2) family of transcription factors ⁶⁵ Negative regulation of activity of TFAP2 (AP-2) family transcription factors ⁶⁵ TFAP2 (AP-2) family regulates transcription of cell cycle factors ⁶⁵ TFAP2 (AP-2) family regulates transcription of growth factors and their receptors ⁶⁵ TFAP2 (AP-2) family regulates transcription of other transcription factors ⁶⁵ TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation ⁶⁵	11.43	KIT ESR1 ERBB2 EGFR
17	B Cell Development Pathways ⁶⁴	11.27	MME KIT CD34
18	Central carbon metabolism in cancer ³⁶	10.76	TP53 KIT ERBB2 EGFR

Sources

GO Terms for Breast Malignant Phyllodes Tumor

Cellular components related to Breast Malignant Phyllodes Tumor according to GeneCards Suite gene sharing:

(showing 1, show less)

#	Name	GO ID	Score	Top Affiliating Genes
1	basal plasma membrane	GO:0009925	8.8	ERBB2 EGFR CD34

Biological processes related to Breast Malignant Phyllodes Tumor according to GeneCards Suite gene sharing:

(showing 16, show less)

#	Name	GO ID	Score	Top Affiliating Genes
1	positive regulation of gene expression	GO:0010628	9.86	TP53 KIT ERBB2 CD34
2	peptidyl-tyrosine phosphorylation	GO:0018108	9.72	KIT ERBB2 EGFR
3	transmembrane receptor protein tyrosine kinase signaling pathway	GO:0007169	9.71	KIT ERBB2 EGFR
4	negative regulation of gene expression	GO:0010629	9.67	TP53 PGR ESR1 CD34
5	wound healing	GO:0042060	9.63	TP53 ERBB2 EGFR
6	replicative senescence	GO:0090399	9.52	TP53 MME
7	positive regulation of phospholipase C activity	GO:0010863	9.51	KIT ESR1
8	tongue development	GO:0043586	9.49	KIT EGFR
9	positive regulation of RNA polymerase II transcriptional preinitiation complex assembly	GO:0045899	9.48	TP53 ESR1
10	positive regulation of production of miRNAs involved in gene silencing by miRNA	GO:1903800	9.43	TP53 EGFR
11	negative regulation of production of miRNAs involved in gene silencing by miRNA	GO:1903799	9.4	TP53 ESR1
12	positive regulation of MAP kinase activity	GO:0043406	9.33	KIT ERBB2 EGFR
13	paracrine signaling	GO:0038001	9.32	PGR CD34
14	negative regulation of ERBB signaling pathway	GO:1901185	9.26	ERBB2 EGFR
15	positive regulation of protein kinase B signaling	GO:0051897	9.26	KIT ESR1 ERBB2 EGFR
16	regulation of transcription by RNA polymerase II	GO:0006357	9.1	TP53 MED12 KIT ESR1 ERBB2 EGFR

Molecular functions related to Breast Malignant Phyllodes Tumor according to GeneCards Suite gene sharing:

(showing 7, show less)

#	Name	GO ID	Score	Top Affiliating Genes
1	chromatin binding	GO:0003682	9.71	TP53 MED12 ESR1 EGFR
2	enzyme binding	GO:0019899	9.62	TP53 PGR ESR1 EGFR
3	transcription factor binding	GO:0008134	9.56	TP53 MED12 ESR1 CD34
4	protein tyrosine kinase activity	GO:0004713	9.54	KIT ERBB2 EGFR
5	protein phosphatase binding	GO:0019903	9.33	TP53 ERBB2 EGFR
6	nitric-oxide synthase regulator activity	GO:0030235	8.96	ESR1 EGFR
7	transmembrane receptor protein tyrosine kinase activity	GO:0004714	8.8	KIT ERBB2 EGFR

Sources

Sources for Breast Malignant Phyllodes Tumor

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HMDB

³¹ HPO

³² ICD10

³³ ICD10 via Orphanet

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ KEGG

³⁷ LifeMap

³⁸ LncRNADisease

³⁹ LOVD

⁴⁰ MalaCards

⁴¹ MedGen

⁴² MedlinePlus

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NIH Rare Diseases

⁵³ NINDS

⁵⁴ Novoseek

⁵⁵ Novus Biologicals

⁵⁶ OMIM

⁵⁷ OMIM via Orphanet

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubMed

⁶² PubMed Health

⁶³ QIAGEN

⁶⁴ R&D Systems

⁶⁵ Reactome

⁶⁶ Sino Biological

⁶⁷ SNOMED-CT

⁶⁸ SNOMED-CT via HPO

⁶⁹ TGDB

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ Wikipedia